Anagrelide Teva

Medicinal product

(Invented) name

Anagrelide Teva

Active substance (s)

Anagrelidas

Strength

0,5 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01XX35, Anagrelide

Marketing authorisation holder

Teva B.V., Nyderlandai

Date of authorisation

2017-12-27

Date of renewal

2022-09-09

Documents

4175 Pakuotės lapelis 2022 11 05.docx

4175 Anagrelide Teva PCS PL 2022 11 05.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

AT/H/0918/001

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Anagrelidas	0,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
98636	84740	1084740	buteliukas	N42		Receptinis	LT/1/17/4175/001	Netiekiama	-	-	No	-	-
98637	84741	1084741	buteliukas	N100		Receptinis	LT/1/17/4175/002	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2022-09-09	Perregistruotas
2017-12-27	Registruotas